Invesco Pharmaceuticals ETF (PJP) Implied Volatility Current

Tracking PJP implied volatility helps you identify when options premiums on Invesco Pharmaceuticals ETF are historically cheap or expensive, and where the best trades are hiding. Invesco Pharmaceuticals ETF implied volatility reflects the market's expectation of future price movement: when PJP IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Invesco Pharmaceuticals ETF's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For PJP, tracking metrics like PJP IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on PJP signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

The Invesco Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.

The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November. As of 08/31/2025 the Fund had an overall rating of 4 stars out of 164 funds and was rated 5 stars out of 164 funds, 5 stars out of 151 funds and 2 stars out of 118 funds for the 3-, 5- and 10- year periods, respectively. Source: Morningstar Inc. Ratings are based on a risk-adjusted return measure that accounts for variation in a fund's monthly performance, placing more emphasis on downward variations and rewarding consistent performance. Open-end mutual funds and exchange-traded funds are considered a single population for comparison purposes. Ratings are calculated for funds with at least a three year history. The overall rating is derived from a weighted average of three-, five- and 10-year rating metrics, as applicable, excluding sales charges and including fees and expenses. ©2025 Morningstar Inc. All rights reserved. The information contained herein is proprietary to Morningstar and/or its content providers. It may not be copied or distributed and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance does not guarantee future results. The top 10% of funds in a category receive five stars, the next 22.5% four stars, the next 35% three stars, the next 22.5% two stars and the bottom 10% one star. Ratings are subject to change monthly. Had fees not been waived and/or expenses reimbursed currently or in the past, the Morningstar rating would have been lower. Ratings for other share classes may differ due to different performance characteristics.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where PJP implied volatility sits today versus where it has been. Our scanner ranks Invesco Pharmaceuticals ETF implied volatility against its historical range, surfaces extremes in PJP IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Invesco Pharmaceuticals ETF IV is rich or cheap — measure it, then act on it.